Azithromycin favored over roflumilast for protecting against COPD exacerbations

Key takeaways:

• Researchers found a lower risk for first moderate or severe COPD exacerbation with azithromycin vs. roflumilast.
• In all but two subgroups, this finding held true.

Read the full article